What does this study add to our knowledge?
There are no reported studies that identify treatment regimens of
nitazoxanide for SARS-CoV-2 treatment or prevention. The current study
provides evidence-based alternative dosing regimens of nitazoxanide for
SARS-CoV-2 treatment and prevention that exceeds antiviral
EC90s in key tissues and organs for the duration of the
dosing interval.